Johnson & Johnson (JNJ)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
163.65-2.10 (-1.27%)
As of 10:31AM EDT. Market open.
| Previous close | 165.75 |
| Open | 165.68 |
| Bid | 163.69 x 800 |
| Ask | 163.71 x 1200 |
| Day's range | 163.33 - 165.76 |
| 52-week range | 133.65 - 179.92 |
| Volume | 1,267,988 |
| Avg. volume | 5,903,126 |
| Market cap | 430.805B |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | 24.46 |
| EPS (TTM) | 6.69 |
| Earnings date | 25 Jan 2022 |
| Forward dividend & yield | 4.24 (2.56%) |
| Ex-dividend date | 22 Nov 2021 |
| 1y target est | 188.82 |
- Editor's pickYahoo Finance Video
University Hospital to mandate boosters for those who received JNJ vaccine
University Hospital CEO and Fmr. Health Commissioner of New Jersey Dr. Shereef Elnahal joins the Yahoo Finance Live panel to discuss the latest outlook for COVID-19 as health officials continue to debate vaccine booster shots.
- Motley Fool
3 Top COVID Stocks -- Are They Tricks or Treats?
Taylor Carmichael (Novavax): Novavax's COVID-19 vaccine is still not on the market anywhere, which has made the stock a real wild ride for investors. The vaccine specialist started off 2020 so small it almost qualified as a micro-cap, with its stock priced at $4 a share. When COVID-19 hit, however, the stock took off.
- Zacks
Should WisdomTree U.S. LargeCap Dividend ETF (DLN) Be on Your Investing Radar?
Style Box ETF report for DLN
© 2021 Verizon Media. All rights reserved.
